Endothelin-1 receptor blockade induces upregulation of renin-angiotensin- aldosterone system expression in terms of blood pressure regulation

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 11, Issue 2, 2010, Pages 119-123

  Yang, Bo ^a   Chen, Yun Dai ^a   Li, Tian De ^a   Feng, Quan Zhou ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Blockade; Blood pressure; Endothelin system; Renin angiotensin aldosterone system (RAAS)

Indexed keywords

ANGIOTENSINOGEN; BOSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; ENDOTHELIN 1 RECEPTOR; ENDOTHELIN RECEPTOR; MESSENGER RNA; PLACEBO; RENIN; UNCLASSIFIED DRUG; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; KIDNEY; LIVER; LUNG; MALE; MONOTHERAPY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

ANGIOTENSINOGEN; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOTTING, NORTHERN; KIDNEY; LIVER; LUNG; MICE; MICE, INBRED C57BL; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ENDOTHELIN A; RENIN; RENIN-ANGIOTENSIN SYSTEM; SYSTOLE; TETRAZOLES; UP-REGULATION; VALINE;

EID: 77953226954     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309358108     Document Type: Article

References (20)

1. Qian C., Schoemaker RG, van Gilst WH, Roks AJ The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function. Clin Sci (Lond) 2009; 116: 301-314.
2. Recchia AG, Filice E., Pellegrino D., Dobrina A., Cerra MC, Maggiolini M. Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes. J Mol Cell Cardiol 2009; 46: 352-359.
3. Abel-Sayed S., Nussberger J., Aubert JF, Gohlke P., Brunner HR, Brakch N. Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects. Am J Hypertens 2003; 16: 515-521.
4. Cardillo C., Campia U., Kilcoyne CM, Bryant MB, Panza JA Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 2002; 105: 452-456.
5. Alvi FM, Hasnain S. Angiotensinogen gene variants in a Pakistani hypertensive population of Punjab. J Renin Angiotensin Aldosterone Syst 2008; 9: 27-31.
6. Shreenivas S., Oparil S. The role of endothelin-1 in human hypertension. Clin Hemorheol Microcirc 2007; 37: 157-178.
7. Feldstein C., Romero C. Role of endothelins in hypertension. Am J Ther 2007; 14: 147-153.
8. Emoto N., Nurhantari Y., Alimsardhono H. et al. Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-1a mediated by novel signals in its alternatively spliced cytoplasmic tail. J Biol Chem 1999; 274: 1509-1518.
9. Nonaka H., Emoto N., Ikeda K. et al. Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation 2001; 104: 1746-1748.
10. Yanagisawa M., Kurihara H., Kimura S. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
11. Atlas SA The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 2007; 13: 9-20.
12. Hernandez-Hernandez R., Sosa-Canache B., Velasco M., Armas-Hernandez MJ, Armas-Padilla MC, Cammarara R. Angiotensin II receptor antagonists role in arterial hypertension. J Hum Hypertens 2002; 16: S93-9.
13. Ibrahim MM RAS inhibition in hypertension. J Hum Hypertens 2006; 20: 101-108.
14. Carey RM, Siragy HM Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003; 24: 261-271.
15. Pagliaro P., Penna C. Rethinking the renin-angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther 2005; 19: 77-87.
16. Paul M., Poyan-Mehr A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
17. Nickenig G., Ostergren J., Struijker-Boudier H. Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers. J Renin Angiotensin Aldosterone Syst 2006; 7: S1-7.
18. Meredith PA, Ostergren J. From hypertension to heart failure-are there better primary prevention strategies? J Renin Angiotensin Aldosterone Syst 2006; 7: 64-73.
19. Wang J., Ho L., Chen L. et al. Valsartan lowers brain Î2-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 2007; 117: 3393-3402.
20. Tran LT, MacLeod KM, McNeill JH Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats. Mol Cell Biochem 2009; 325: 89-97.